CRL
Price
$164.17
Change
+$0.18 (+0.11%)
Updated
Sep 8, 12:46 PM (EDT)
Capitalization
8.07B
51 days until earnings call
LUCD
Price
$1.37
Change
-$0.01 (-0.72%)
Updated
Sep 5 closing price
Capitalization
139.59M
70 days until earnings call
Interact to see
Advertisement

CRL vs LUCD

Header iconCRL vs LUCD Comparison
Open Charts CRL vs LUCDBanner chart's image
Charles River Laboratories International
Price$164.17
Change+$0.18 (+0.11%)
Volume$700
Capitalization8.07B
Lucid Diagnostics
Price$1.37
Change-$0.01 (-0.72%)
Volume$3.12M
Capitalization139.59M
CRL vs LUCD Comparison Chart in %
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRL vs. LUCD commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and LUCD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CRL: $163.99 vs. LUCD: $1.37)
Brand notoriety: CRL and LUCD are both not notable
CRL represents the Medical Specialties, while LUCD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CRL: 71% vs. LUCD: 318%
Market capitalization -- CRL: $8.07B vs. LUCD: $139.59M
CRL [@Medical Specialties] is valued at $8.07B. LUCD’s [@Medical/Nursing Services] market capitalization is $139.59M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.69B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileLUCD’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • LUCD’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRL and LUCD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 7 TA indicator(s) are bullish while LUCD’s TA Score has 6 bullish TA indicator(s).

  • CRL’s TA Score: 7 bullish, 2 bearish.
  • LUCD’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, CRL is a better buy in the short-term than LUCD.

Price Growth

CRL (@Medical Specialties) experienced а +0.42% price change this week, while LUCD (@Medical/Nursing Services) price change was +8.73% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

Reported Earning Dates

CRL is expected to report earnings on Oct 29, 2025.

LUCD is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($8.07B) has a higher market cap than LUCD($140M). LUCD YTD gains are higher at: 67.338 vs. CRL (-11.165). CRL has higher annual earnings (EBITDA): 528M vs. LUCD (-54.36M). CRL has more cash in the bank: 183M vs. LUCD (31.1M). LUCD has less debt than CRL: LUCD (27.6M) vs CRL (2.79B). CRL has higher revenues than LUCD: CRL (4.03B) vs LUCD (4.36M).
CRLLUCDCRL / LUCD
Capitalization8.07B140M5,765%
EBITDA528M-54.36M-971%
Gain YTD-11.16567.338-17%
P/E Ratio577.05N/A-
Revenue4.03B4.36M92,408%
Total Cash183M31.1M588%
Total Debt2.79B27.6M10,094%
FUNDAMENTALS RATINGS
CRL: Fundamental Ratings
CRL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRLLUCD
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
69%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
69%
Bearish Trend 27 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
78%
Aroon
ODDS (%)
Bullish Trend 7 days ago
70%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FNNCF7.680.10
+1.32%
Financial 15 Split Corp
TCMFF1.29N/A
N/A
Telecom Argentina S.A.
NILTF0.03N/A
N/A
NICAN LTD.
KYOCF12.05-0.95
-7.31%
Kyocera Corp.
MBGPF0.95-0.10
-9.52%
MOBERG PHARMA AB

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RVTY. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+1.04%
RVTY - CRL
60%
Loosely correlated
+1.10%
NOTV - CRL
58%
Loosely correlated
+2.50%
ICLR - CRL
58%
Loosely correlated
-0.84%
A - CRL
58%
Loosely correlated
+0.21%
AZTA - CRL
56%
Loosely correlated
+2.64%
More

LUCD and

Correlation & Price change

A.I.dvisor tells us that LUCD and NOTV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and NOTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-0.72%
NOTV - LUCD
32%
Poorly correlated
+2.50%
FEMY - LUCD
31%
Poorly correlated
+2.09%
CRL - LUCD
26%
Poorly correlated
+1.04%
BWAY - LUCD
24%
Poorly correlated
-0.75%
NTRA - LUCD
23%
Poorly correlated
+0.88%
More